Skip to main content

Table 1 Association between potential risk factors and stroke after hip fracture surgeries

From: Incidence and risk factors associated with postoperative stroke in the elderly patients undergoing hip fracture surgery

Variables

Number (%) of stroke (n = 56)

Number (%) of non-stroke (n = 3687)

P

Gender (male)

19 (33.9)

1573 (42.7)

0.189

Age (years)

80.3 ± 8.5

78.1 ± 11.4

0.001

Living place

0.482

 Rural

29 (51.8)

1735 (47.1)

 

 Urban

27 (48.2)

1952 (52.9)

 

BMI (kg/m2)

24.7 ± 5.6

25.4 ± 3.9

0.672

 18.5–23.9

24 (42.9)

1368 (37.1)

0.221

 < 18.5

5 (8.9)

198 (5.4)

 

 24.0–27.9

17 (30.4)

1595 (43.3)

 

 ≥ 28.0

10 (17.9)

526 (14.3)

 

Diabetes mellitus

11 (19.6)

538 (14.6)

0.289

Hypertension

19 (33.9)

895 (24.3)

0.095

Chronic heart disease

7 (12.5)

362 (9.8)

0.504

Past stroke

11 (19.6)

287 (7.8)

0.001

Chronic use of aspirin

10 (17.9)

325 (8.8)

0.019

Injury mechanism (low-energy)

53 (94.6)

3521 (95.5)

0.760

Preoperative stay

4.6 ± 3.2

4.3 ± 2.6

0.278

Total hospital stay

14.4 ± 7.4

15.1 ± 7.9

0.443

Intraoperative bleeding

286.6 ± 304.2

278 ± 187.1

0.643

Surgical duration

106.5 ± 47.0

97.8 ± 51.4

0.074

Cigarette smoking

9 (16.1)

774 (21.0)

0.369

Alcohol consumption

13 (23.2)

1402 (38.0)

0.023

Fracture type

0.149

Femoral neck

25 (44.6)

2005 (54.3)

 

Intertrochanteric

31 (55.4)

1686 (45.7)

 

Procedure

0.103

 Osteosynthesis

47 (83.9)

2742 (74.4)

 

 Arthroplasty

9 (16.1)

945 (25.6)

 

Anesthesia

  

0.145

 Local

2 (3.6)

134 (3.6)

 

 Spinal

23 (41.1)

1989 (53.9)

 

 General

31 (55.4)

1564 (42.4)

 

ASA class

0.007

 I-II

31 (55.4)

2642 (71.7)

 

 III or above

25 (44.6)

1045 (28.3)

 

TP (g/L)

54.1 ± 7.9

59.2 ± 7.2

0.005

ALB (g/L)

28.4 ± 4.5

33.6 ± 5.5

<0.001

ALT (U/L)

25.3 ± 19.4

24.5 ± 23.7

0.579

AST (U/L)

26.7 ± 16.4

26.2 ± 23.8

0.752

FBG (mmol/L)

5.1 ± 2.2

5.0 ± 1.9

0.896

TC (mmol/L)

3.8 ± 0.9

3.5 ± 0.7

0.103

TG (mmol/L)

1.3 ± 0.6

1.1 ± 0.7

0.164

LDL-C (mmol/L)

2.2 ± 0.6

2.4 ± 0.7

0.489

HDL-C (mmol/L)

0.9 ± 0.4

1.2 ± 0.3

0.016

VLDL (mmol/L)

0.6 ± 0.3

0.5 ± 0.3

0.133

WBC (109/L)

9.0 ± 3.1

8.7 ± 3.3

0.673

NEUT (109/L)

6.9 ± 2.9

6.9 ± 2.8

0.907

LYM (109/L)

1.2 ± 0.6

1.1 ± 0.6

0.918

RBC (< lower limit)

26 (46.4)

2078 (56.4)

0.137

HGB (< lower limit)

19 (33.9)

858 (23.3)

0.062

HCT (< lower limit)

4 (7.1)

97 (2.6)

0.039

PLT (< 100 × 109/L)

4 (7.1)

127 (3.4)

0.135

PDW (%)

15.7 ± 3.4

15.1 ± 2.4

0.176

RDW (%)

15.8 ± 1.5

14.1 ± 1.8

0.014

  1. BMI Body mass index, ASA American Society of Anesthesiologists, RBC Red blood cell; reference range: female, 3.5–5.0/1012/L; males, 4.0–5.5/1012/L. HGB Hemoglobin; reference range: females, 110–150 g/L; males, 120–160 g/L. FBG Fasting blood glucose, ALT Alkaline phosphatase, HCT Hematocrit; 40–50%. WBC White blood cell, NEUT Neutrophile, LYM Lymphocyte, PLT Platelet; 100–300 × 109/L. TP Total protein, ALB Albumin, GLOB Globulin, RDW Red cell distribution width, PDW Platelet distribution width, TC Total cholesterol, TG Triglyceride, LDL-C Low-density lipoprotein, HDL-C High-density lipoprotein, VLDL Very low-density lipoprotein